| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/17.SUPPL_A.25 |
| P698 | PubMed publication ID | 3011726 |
| P2093 | author name string | Carlet J | |
| Gutmann L | |||
| Desplaces N | |||
| Acar JF | |||
| Guibert J | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | quinolones | Q426549 |
| P304 | page(s) | 25-39 | |
| P577 | publication date | 1986-03-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | The new quinolones and their combinations with other agents for therapy of severe infections | |
| P478 | volume | 17 Suppl A |
| Q72064357 | A prospective, randomized study of pefloxacin versus teicoplanin in the treatment of gram-positive coccal infections in cancer patients: early termination due to emergence of resistance to fluoroquinolones |
| Q35310408 | Activities of five new fluoroquinolones against Pseudomonas pseudomallei |
| Q40939797 | Activity of quinolones against gram-positive cocci: clinical features |
| Q43700807 | Antibiotic Therapy in Osteomyelitis in Outpatients |
| Q45147733 | Assessment of immunomodulating activity of ofloxacin and three other quinolones in human plasma |
| Q35897284 | Characterization of Acinetobacter haemolyticus aac(6')-Ig gene encoding an aminoglycoside 6'-N-acetyltransferase which modifies amikacin |
| Q40283892 | Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa |
| Q39828366 | Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance |
| Q50195000 | Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics |
| Q46528296 | Epidemiological study of Staphylococcus aureus resistance to new quinolones in a university hospital |
| Q38969461 | Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis |
| Q54313087 | First clinical isolate of highly fluoroquinolone-resistant Escherichia coli in Scandanavia. |
| Q39534055 | Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use. |
| Q69548929 | Fluoroquinolone antimicrobial agents |
| Q40506281 | Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana). |
| Q35542064 | In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs |
| Q67290043 | In vitro bactericidal activity of amoxicillin, gentamicin, rifampicin, ciprofloxacin and trimethoprim-sulfamethoxazole alone or in combination against Listeria monocytogenes |
| Q54393974 | In vitro selection of Escherichia coli mutants with decreased susceptibility to norfloxacin. |
| Q73588660 | Influence of pH and pKa values on electrophoretic behaviour of quinolones in aqueous and hydro-organic media |
| Q35897356 | Influence of rifampin on fleroxacin pharmacokinetics |
| Q33722507 | Interaction between ciprofloxacin and rifampin |
| Q43658064 | Intravenous ciprofloxacin for the treatment of severe infections |
| Q42199003 | Neurochemical studies on quinolone antibiotics: effects on glutamate, GABA and adenosine systems in mammalian CNS. |
| Q34687048 | Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application |
| Q67929165 | Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients |
| Q38322827 | Quinolone antimicrobial agents: adverse effects and bacterial resistance |
| Q46653985 | The effect of ciprofloxacin on cyclophosphamide pharmacokinetics in patients with non-Hodgkin lymphoma |
| Q28296928 | The role of quinolones in the treatment of chronic bacterial prostatitis |
| Q35353352 | Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis |
| Q58405400 | Treatment recommendations and strategies for the management of bone and joint infections |
| Q37222611 | Use of quinolones in treatment of prostatitis and lower urinary tract infections |
Search more.